Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud…
A pooled analysis from the AURA-LV and AURORA 1 studies, also presented at ERA, showed early treatment response to LUPKYNIS with reductions in proteinuria across lupus nephritis biopsy classes Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)…